SEACROSS
LIVE

Serial Number

79125400

Owner

Sichuan Huiyu Pharmaceutical Co., Ltd.

Filing Date

Nov 7, 2012

Add to watchlist:

No watchlists yet
View on USPTO

SEACROSS Trademark

Serial Number: 79125400 • Registration: 4394496

SEACROSS is a trademark filed by Sichuan Huiyu Pharmaceutical Co., Ltd. on November 7, 2012. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 39 (Transportation & Storage), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Sichuan Huiyu Pharmaceutical Co., Ltd. (5 trademarks)

Building 3
Neijiang, Sichuan 641000 , CN

Entity Type: 99

Seacross Pharmaceuticals Limited

Landmark House

Entity Type: 16

Trademark Details

Filing Date

November 7, 2012

Registration Date

September 3, 2013

Published for Opposition

June 18, 2013

Cancellation Date

November 8, 2022

Goods & Services

[ Distribution, storage and transportation ] * Warehousing services, namely, storage, distribution, pick-up, packing, and shipping * of pharmaceutical products and medical apparatus, instruments and devices; information, advisory and consultancy services relating to all of the aforesaid

Pharmaceutical preparations, namely, anti-bacterial, anti-diabetic, anti-viral, anti-sickness, anti-infective and cardiovascular treatment pharmaceuticals, anti-allergic pharmaceutical preparations, pharmaceutical preparations for the treatment of infectious diseases and disorders of the central nervous system, pharmaceutical preparations for hormonal deficiencies, erectile dysfunction and reproductive dysfunction, pharmaceutical preparations for use in oncology, veterinary preparations, namely, therapeutic anti-infective, anti-bacterial, anti-sickness and anti-allergic pharmaceuticals and therapeutic veterinary preparations, namely, pharmaceuticals for the treatment of infectious diseases, hormonal deficiencies and for use in oncology, all for livestock and domestic animals; sanitary preparations for medical purposes; dietetic foods adapted for medical use; material for stopping teeth; vaccines

Marketing * services namely, promoting or advertising the goods and services of others *; marketing support services [to third parties] * namely, advertising and marketing of pharmaceutical and diagnostic preparations, therapeutics, medical apparatus, instruments and devices of third parties to enable them to be accepted and sold for worldwide distribution* ; creation of marketing partnerships between companies *, namely, cooperative advertising and marketing of pharmaceutical * companies as partners and their intellectual property licenses for the regulatory acceptance and sale of pharmaceuticals [ relating to the sale and ] * distribution of pharmaceutical products,* medical apparatus, instruments and devices * for worldwide distribution*; advertising * agencies *; business development; business sales advisory services; sourcing in the nature of procurement, namely, purchasing for others pharmaceutical products and medical apparatus, instruments and devices from third parties for worldwide distribution; import-export agency services; [ auditing services relating to regulatory guidance in respect of ] * business auditing and preparation of business reports in the field of * pharmaceutical products, and medical apparatus, instruments and devices * f or the purpose of regulatory guidance *; executive recruitment of management staff and personnel for pharmaceuticals and life sciences companies; business advisory and management services relating to company acquisitions and to identify and negotiate company acquisitions for third parties; business management and advisory services relating to obtaining marketing authorisations from relevant governing authorities in respect of pharmaceutical products, medical apparatus, instruments and devices; computerised database management; compilation and systemization of information into computer databases; commercial information services provided by access to a computer database; all of the aforesaid also provided online via the Internet or other interactive electronic platforms; information, advisory and consultancy services relating to all of the aforesaid

Licensing of pharmaceutical products; licensing * intellectual property * [ of ] * for * research and development; issuing of patent and intellectual property licences relating to pharmaceutical products, medical apparatus, instruments and devices; issuing of regulatory * compliance * information in the field of pharmaceuticals, medical devices, apparatus and instruments; [ legal services relating to the provision of pharmaceutical regulatory advice, guidance and information and the acquisition of companies and the acquisition of intellectual property; legal document or report preparation services relating to regulatory guidance in respect of pharmaceutical products, and medical apparatus, instruments and devices; ] information, advisory and consultancy services relating to all of the aforesaid

Surgical, medical, veterinary and dental devices, apparatus and instruments *namely, drug delivery systems, knives for surgical use, lasers for surgical and medical use, catheters for surgical use, and surgical and medical apparatus and instruments for use in general surgery*; artificial limbs, eyes and teeth; orthopaedic articles * namely, orthopaedic apparatus and instruments for diagnostic and therapeutic use*; suture materials

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
May 29, 2023 DENC
DEATH OF INTERNATIONAL REGISTRATION
May 29, 2023 DETH
TOTAL INVALIDATION PROCESSED BY THE IB
Feb 27, 2022 INNT
GENERIC MADRID TRANSACTION SENT TO IB
Jan 27, 2022 XXSS
GENERIC MADRID TRANSACTION CREATED
Jan 26, 2022 XXCR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Oct 26, 2021 INTR
CANCELLED SECTION 71
Feb 26, 2021 C71T
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jul 23, 2020 ADCH
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Sep 3, 2018 REM3
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Jul 6, 2017 INNA
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Jul 2, 2017 INPR
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
Nov 14, 2016 CORR
ELECTRONIC RECORD REVIEW COMPLETE
Nov 4, 2016 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Nov 4, 2016 ERRR
CORRECTION UNDER SECTION 7 - PROCESSED
Nov 2, 2016 COC.
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Nov 2, 2016 APRE
CHANGE OF OWNER RECEIVED FROM IB
May 21, 2015 CHLD
CORRECTION TRANSACTION RECEIVED FROM IB
May 16, 2015 CRCV
NEW REPRESENTATIVE AT IB RECEIVED
Nov 14, 2014 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Jan 25, 2014 FINO
NEW REPRESENTATIVE AT IB RECEIVED
Dec 13, 2013 NREP
FINAL DISPOSITION NOTICE SENT TO IB
Dec 6, 2013 FICS
FINAL DISPOSITION PROCESSED
Dec 6, 2013 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 3, 2013 FICR
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Sep 10, 2013 CORN
CORRECTION TRANSACTION RECEIVED FROM IB
Sep 6, 2013 CRCV
REGISTERED-PRINCIPAL REGISTER
Sep 3, 2013 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 18, 2013 NPUB
PUBLISHED FOR OPPOSITION
Jun 18, 2013 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 29, 2013 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
May 14, 2013 PREV
ASSIGNED TO LIE
May 13, 2013 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
May 3, 2013 CNSA
EXAMINER'S AMENDMENT ENTERED
May 3, 2013 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 3, 2013 GNEN
EXAMINERS AMENDMENT E-MAILED
May 3, 2013 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 3, 2013 CNEA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 2, 2013 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 2, 2013 REAP
REFUSAL PROCESSED BY IB
Apr 16, 2013 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 15, 2013 RFCS
REFUSAL PROCESSED BY MPU
Mar 15, 2013 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 15, 2013 RFCR
NON-FINAL ACTION WRITTEN
Mar 14, 2013 CNRT
ASSIGNED TO EXAMINER
Mar 6, 2013 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 1, 2013 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 25, 2013 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Feb 22, 2013 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 21, 2013 REPR